June 2021
243 articles-
Jun 30 · 13:32Biotechnology Daily
Lilly to file for accelerated FDA approval of Alzheimer's drug after Aduhelm OK opens the floodgates
-
Jun 30 · 13:31Biotechnology Daily
Arcus shares scant analysis of phase 2 data on Gilead-partnered TIGIT drug
-
Jun 30 · 13:26Biotechnology Daily
'Let the games begin': Reinvigorated Alzheimer's pipeline breaches the levee with planned Lilly filing, Bristol Myers opt-in
-
Jun 30 · 13:23Biotechnology Daily
With J&J, GSK leading the pack, AbbVie jumps in the multiple myeloma fight with TeneoOne buy
-
Jun 30 · 13:14Bio Business News
Belldegrun's VC firm nabs a major $825M funding well for next-gen biotechs
-
Jun 30 · 13:12Bio Business News
Lyndra banks $60.5M to bring ultralong-acting pill into pivotal schizophrenia trial
-
Jun 30 · 13:10Bio Business News
Monte Rosa sticks its Nasdaq landing, banking $222M for 'molecular glues'
-
Jun 30 · 13:06Bio Business News
Boston Scientific shells out a hearty $295M for Farapulse's electric-field-generating afib treatment
-
Jun 30 · 12:32Market Watch
Oil trims gains after fall in inventories, attention turns to OPEC+
-
Jun 30 · 12:28Market Watch
Cybersecurity company SentinelOne IPO prices above range at $35 a share
-
Jun 30 · 12:26Market Watch
Xometry IPO prices at $44 a share, above proposed price range of $38 to $42
-
Jun 30 · 12:23Market Watch
Luckin Coffee stock jumps after financial restatement
-
Jun 29 · 10:31Biotechnology Daily
Galapagos CSO Wigerinck hits the bricks after major setbacks
-
Jun 29 · 10:30Biotechnology Daily
Abata hopes to find ‘perfect fit’ with MS cell therapy after $95M series A
-
Jun 29 · 10:27Biotechnology Daily
New FDA papers reveal internal split over Biogen's Aduhelm approval
-
Jun 29 · 10:26Biotechnology Daily
Meet Hugo: Medtronic's robotic-assisted surgery system makes global debut in Chilean clinic
-
Jun 29 · 10:23Bio Business News
After rebounding from FDA setback, uniQure goes all in on gene therapy with $55M Corlieve buy
-
Jun 29 · 10:22Bio Business News
Digital therapy maker Pear Therapeutics shakes the money tree, with plans to go public in $1.6B SPAC deal
-
Jun 29 · 10:20Bio Business News
Moove over IPO: SAB Biotherapeutics to milk the stock market via SPAC
-
Jun 29 · 10:19Bio Business News
TRexBio has Jurassic day picking up ex-Lilly VP as CEO, snagging Big Pharma funding
-
Jun 29 · 09:43Market Watch
Fed official says another boom-and-bust housing market is not sustainable
-
Jun 29 · 09:35Market Watch
Duolingo, the fast-growing language-learning app, files for IPO
-
Jun 28 · 10:25Biotechnology Daily
Smartphone AI app capable of reading HIV test results in low-resource settings, study finds
-
Jun 28 · 10:23Biotechnology Daily
Medtronic freezes out the competition with expanded FDA OK for afib cryoablation catheter